This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
AUA 2012 - The absence of goal setting in the dialogue between metastatic prostate cancer (mCRPC) patients and their physicians: An opportunity for shared decision making? - Another Perspective
May 30, 2012
AUA 2012 - Does long-term aspirin use lower serum PSA levels? – Results from the Duke Prostate Center - Session Highlights
May 30, 2012
AUA 2012 - Unilateral prostate cancer: Analysis of predictors in search and Duke Prostate Center databases - Session Highlights
May 30, 2012
The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: Magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans
May 30, 2012
AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD
May 30, 2012
Management of patients with metastatic prostate cancer - Abstract
May 29, 2012
Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort - Abstract
May 29, 2012
Active surveillance for favorable-risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes - Abstract
May 29, 2012
EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy - Abstract
May 29, 2012
Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations - Abstract
May 29, 2012
Androgen deprivation therapy in prostate cancer. Indication and systemic consequences - Abstract
May 29, 2012
Patterns of prostate-specific antigen (PSA) testing in Australian men: The influence of family history - Abstract
May 29, 2012
Cancer overdiagnosis and overtreatment - Abstract
May 29, 2012
The role of 5-alpha-reductase inhibitors in active surveillance - Abstract
May 29, 2012
Prostate cancer epidemiology in the United States - Abstract
May 29, 2012
Q Fever masquerading as prostate cancer metastases - Abstract
May 28, 2012
Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings - Abstract
May 28, 2012
Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer - Abstract
May 28, 2012
Health economics evaluation of magnetic resonance imaging for the staging of prostate cancer for Austria and Germany - Abstract
May 28, 2012
Novel agents for the management of castration-resistant prostate cancer - Abstract
May 28, 2012
Page 1291 of 1438
Start
Prev
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free